Resistin, obesity, and insulin resistance - The emerging role of the adipocyte as an endocrine organ

New England Journal of Medicine

Volumn 345, Issue 18, 2001, Pages 1345-1346

  Shuldiner, Alan R ^a   Yang, Rongze ^a   Gong, Da Wei ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; RESISTIN; ROSIGLITAZONE; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; DYSLIPIDEMIA; ENDOCRINE GLAND; HORMONE ACTION; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; WEIGHT GAIN;

ADIPOCYTES; ANIMALS; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; HORMONES, ECTOPIC; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NERVE GROWTH FACTOR; OBESITY; PROTEINS; RESISTIN;

EID: 0035522298     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200111013451814     Document Type: Article

References (5)

1. Early detection of undiagnosed diabetes mellitus: A US perspective
2. Adipose tissue as an endocrine organ
3. The hormone resistin links obesity to diabetes
4. Dimerization of resistin and resistin-like molecules is determined by a single cysteine
5. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation